Emerald Advisers’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Emerald Advisers’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,655,711	Closed	-$6.18M	–	372
2020 Q3	$6.18M	Sell	1,655,711 -450,762	-21%	-$1.92M	0.25%	102
2020 Q2	$9.18M	Buy	2,106,473 +5,844	+0.3%	+$26.3K	0.4%	92
2020 Q1	$7.96M	Buy	2,100,629 +17,503	+0.8%	+$86K	0.46%	79
2019 Q4	$13.2M	Sell	2,083,126 -1,559	-0.1%	-$9.16K	0.56%	75
2019 Q3	$8.78M	Buy	2,084,685 +212,553	+11%	+$908K	0.41%	93
2019 Q2	$8.71M	Buy	1,872,132 +137,710	+8%	+$641K	0.35%	101
2019 Q1	$9.19M	Buy	1,734,422 +1,557,692	+881%	+$7.11M	0.37%	100
2018 Q4	$654K	Buy	+176,730	New	+$621K	0.03%	178

Other funds holding BDSI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Emerald Advisers's BDSI Position: Q4 2020 in Review

Emerald Advisers sold out of BioDelivery Sciences International, Inc. (BDSI) in Q4 2020, closing a stake of 1,655,711 shares — an estimated $6.18M sold.

Emerald Advisers first reported a position in BDSI in Q4 2018 and held it in 8 quarters. The position peaked at $13.2M in Q4 2019. 145 funds tracked by Wall St. Rank hold BDSI as of Q4 2020.

Emerald Advisers reported no remaining BioDelivery Sciences International, Inc. position as of Q4 2020 after selling out during the quarter.
Emerald Advisers sold 1,655,711 BioDelivery Sciences International, Inc. shares in Q4 2020, an estimated $6.18M.
Emerald Advisers first reported a position in BioDelivery Sciences International, Inc. in Q4 2018 and held it in 8 quarters.
Emerald Advisers's BioDelivery Sciences International, Inc. position peaked at $13.2M in Q4 2019.
145 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q4 2020.

Based on Emerald Advisers's 13F filing for Q4 2020, filed 29 Jan 2021.